During this segment, Arthur Garson, Jr, MD, MPH, highlights the benefits of an evolving hospital discharge program, Grand-Aides.
Dr Garson discusses the role of a Grand-Aide, commonly a certified nurse aide, and his or her responsibilities to the patient and family members following discharge. He further explains that the Grand-Aide is not the decision maker for the patient, but rather a director of the patient’s care. Through telemedicine, the Grand-Aide records video and relays important information back and forth between a medical supervisor and the patient and family.
Dr Garson also discusses how the Grand-Aides program developed, and explains how the program has effectively improved patient care and reduced hospitalization costs, overall lengths of stay, and rates of readmission.
As this new model of care continues to evolve, Dr Garson explains, it will be important for the CMS to support payment for telemedicine and the Grand-Aides program.
Adults With Diabetes in High-Deductible Health Plans More Likely to Have Severe Hyperglycemia
January 26th 2023Adults with diabetes who were forced to switch from an employer-sponsored health plan to a high-deductible health plan (HDHP) were 25% more likely to require an emergency department (ED) or hospital visit for hyperglycemia, but not for hypoglycemia, than those who did not switch plans.
Read More
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
Exploring Payer Coverage Decisions Following FDA Novel Drug Approvals
May 3rd 2022On this episode of Managed Care Cast, Ari D. Panzer, BS, lead author and researcher, then at Tufts Medical Center—now at Duke University—discusses the findings from his team’s investigation into coverage decisions by health plan insurers of the 66 drugs approved by the FDA in 2018.
Listen
2 Clarke Drive
Cranbury, NJ 08512